Effects of Dexmedetomidine on Cognitive Outcome and Brain Injury Markers After General Anesthesia for Cardiac Surgery on Cardiopulmonary Bypass
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2019
At a glance
- Drugs Dexmedetomidine (Primary) ; Estazolam; Etomidate; Morphine; Nitroglycerin; Pancuronium bromide; Phenylephrine; Propofol; Remifentanil
- Indications Sedation
- Focus Biomarker; Pharmacodynamics
- 19 Feb 2019 Last checked against ClinicalTrials.gov: US National Institutes of Health
- 09 Feb 2019 Planned End Date changed from 31 Dec 2018 to 31 Mar 2019.
- 09 Feb 2019 Status changed from not yet recruiting to active, no longer recruiting.